S

Sensei Biotherapeutics
D

SNSE

29.400
USD
1.00
(3.52%)
قبل الجلسة
حجم التداول
225
الربح لكل سهم
-16
العائد الربحي
-
P/E
-2
حجم السوق
39,404,261
المقالات
المزيد

العنوان: Sensei Biotherapeutics Inc

القطاع: Healthcare
الصناعة: Biotechnology
Sensei Biotherapeutics Inc is a clinical-stage biotechnology company engaged in the development of therapies targeting cancer through multi-node inhibition of oncogenic pathways. The company's lead program, PIKTOR, is an investigational oral combination therapy designed to inhibit multiple nodes of the PI3K/AKT/mTOR pathway and is being evaluated for the treatment of endometrial and breast cancers. In addition, the company is advancing other pipeline programs targeting tumormetabolism and signaling pathways.